Status:
RECRUITING
Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment
Lead Sponsor:
Vanderbilt-Ingram Cancer Center
Conditions:
Melanoma
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this research is to identify biological characteristics occurring in the initiation and progression of melanoma.
Eligibility Criteria
Inclusion
- Inclusion criteria
- Pathologically-proven diagnosis of melanoma.
- Patient must have a test or procedure that has the potential to provide left-over tissue that can be banked for future research purposes OR the patient has already had a diagnostic or therapeutic procedure but who has not yet been approached to participate is also eligible.
- Exclusion criteria
- Any patient with significant contraindications to venipuncture (e.g., severe anemia) will be excluded from blood collection procedures. However, if the patient provides consent and a paraffin-embedded block or 10-15 unstained slides of their tissue diagnosis, they will not be excluded from this protocol.
- Any patient unable or unwilling to provide consent.
Exclusion
Key Trial Info
Start Date :
June 3 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2027
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT01205815
Start Date
June 3 2010
End Date
June 1 2027
Last Update
September 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbitl-Ingram Cancer Center
Nashville, Tennessee, United States